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Abstract 
Gastrointestinal stimulator implants have recently shown positive results in treating obesity. 
However, the implantation currently requires an invasive surgical procedure. Endoscopy could be 
used to place the gastric stimulator in the stomach, hence avoiding the riskier surgery. The implant 
then needs to go through the oesophagus and be located inside the stomach, which imposes new 
design constraints, such as miniaturization and protecting the electronic circuit against the highly 
acidic environment of the stomach. We propose to protect the implant by encapsulation with 
silicone rubber. This paper lists the advantages of this method compared to the more usual 
approach of a hermetic enclosure, then presents a method to evaluate the underwater adhesive 
stability of six adhesive/substrate couples; using repeated lap-shear tests and an elevated 
temperature to accelerate the aging process. The results for different adhesive/substrate couples 
tested, presented on probability plots, show that FR4 and alumina substrates with MED4-4220 
silicone rubber are suitable for a first implantable prototype. We then compare these with the 
predicted lifetimes of bonds between historical standard silicone rubber DC3140 and different 
substrates, and describe the encapsulation of our gastrostimulator. 
Keywords 
Gastric electrical stimulation; endoscopic implantation; obesity; encapsulation; 
packaging; lap-shear test; silicone rubber; accelerated testing. 
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Introduction 
Obesity has reached epidemic proportions throughout the world, with more than 
500 million adults affected [15]. It is commonly associated with various health 
issues such as cardiovascular diseases, diabetes and musculoskeletal disorders 
[38]. Obesity also has important economical consequences both for the obese 
patients and for society [38]. 
Bariatric surgery, mainly recommended to patients with a body mass index (BMI) 
ranging between 30 and 50, is one of the most common techniques used to induce 
weight loss [21]. Although effective, it suffers from important drawbacks such as 
its considerable costs and invasiveness, as well as long term weight regain [20]. 
Gastric electrostimulation, a recent technique aiming to induce satiety by applying 
current pulses to the stomach, has shown promising results in terms of 
effectiveness [19]. However, as laparoscopy is used to implant the 
gastrostimulator, those improvements are somewhat limited as the method is still 
invasive. In this regard, placing the gastrostimulator using endoscopic techniques 
is highly attractive because it would be reversible, less invasive and less 
expensive [21]. Being more affordable and less risky, the technique could be 
offered to a greater number of obese persons.  
Challenges of endoscopically implantable stimulator 
Endoscopically implanted gastrostimulators are however very challenging to 
design [25]. First, due to the passage through the oesophagus, we estimate, based 
on previous experimental studies and existing endoscopic devices [21], that the 
device cannot exceed a maximum volume of 5 cm3 and a diameter of 18 mm. The 
large housings commonly used for implantable electronic devices (such as the 
pacemaker) are therefore unsuitable. Second, the device needs to have adequate 
anchoring in the stomach to avoid migration or detachment and withstand 
stomach contractions. Third, the device needs to be easily secured using 
endoscopic tools. Fourth, the power supply should neither be cumbersome nor 
require too regular endoscopies to replace the implant. Fifth, the device packaging 
must resist the acidic stomach environment, as described hereunder.  
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Implant packaging 
The implant packaging is of major importance as it protects the implant from the 
humid and acidic stomach environment (the pH in the stomach can be as low as 1 
[3]). Packaging prevents corrosion and provide some mechanical protection to the 
components of the electronic circuit, therefore preventing functional failure or 
erratic behaviour of the implant that could present a risk to the patient. The 
material used for the packaging should obviously be biocompatible. 
The most popular packaging method consists in using hermetically sealed 
housings, generally made of metal, ceramic or glass with hermetic feedthroughs. 
The well-known pacemaker has proven that such protections do last for decades. 
However, hermetic hard shells present various drawbacks:  
- They tend to be heavy and bulky, yet, the most popular designs, which were 
initially conceived 50 or more years ago, have reached the limits of 
miniaturisation achievable. This is becoming increasingly relevant with the 
trends towards implant miniaturisation driven by the development of new 
applications, such as gastric implants and others (e.g. retinal and spinal 
stimulation).  
- The manufacturing processes rely on expensive tooling, often build 
specifically to a part’s dimensions, which is a considerable financial burden 
for the production of very small batches, typical of the early prototyping 
stages of a product development.  
- They require feedthrough, since most implants are to interact in some way 
with the human body (recoding, simulation, etc.). Therefore, a further 
protection level is also needed for all conductive parts outside the protective 
shell. This is often achieved with silicone rubber encapsulation. Note that 
some designs use the substrate as a part of the hermetic enclosure [17], 
achieving this way higher feedthrough density, but still requiring silicone 
rubber encapsulation.  
- Hermeticity tests, needed to assess the hard shell’s and seal’s hermeticity, are 
unreliable for implants with a small internal volume [22, 35]. Again, this is 
becoming increasingly problematic since recent implant designs require such 
small dimensions.  
- Hermetic packages often use materials that affect RF communication. 
Although some attempts were made to design a transparent window for RF 
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communication [1, 40, 41], the procedure is very expensive and the resulting 
designs were large.  
Therefore, this protection method is not suitable for many applications, including 
ours.  
Another way of protecting the implant consists in encapsulating all the 
components with silicone rubber. This method is used in commercial applications 
and gives implant lifetimes of several decades [2]. It was briefly reviewed by 
Vanhoestenberghe et al. [36] and the two methods are illustrated in Fig. 1. The 
key to the success of this method is an appreciation that while silicone rubber is 
highly permeable to water vapour [33], its presence over a substrate can prevent 
the formation of liquid water, hence avoiding the formation of conductive paths 
between conductors, and corrosion. Therefore, it is crucial that the silicone rubber 
should strongly adhere to the substrate, and that the manufacturing method should 
prevent the creation of any voids that would lead to water condensation over 
electrical pads. If there is no loss of adhesion between the encapsulant and all the 
surfaces, there will be no corrosion inducing a potential failure. The implant life 
can thus be related to the life of the adhesive joint in situ. It is therefore critical to 
evaluate the long-term stability of the adhesive bond, between the encapsulant and 
the surfaces it covers, under operating conditions. Various silicone rubbers and 
substrates have already been tested in earlier experiments [9–11]. However, to the 
best of our knowledge, no studies have assessed their behaviour in the acidic 
environment of the stomach.  
Further, silicone rubber has already been used to encapsulate a gastrostimulator. 
However, no information were presented justifying the choice of material, and the 
device was removed after two hours in vivo, so that no information regarding 
long-term adhesion, or general efficiency of the protection method, could be 
deduced [5]. 
In this article, we describe the method we use to evaluate the long-term stability 
of the adhesive bond between several couples of substrate and silicone rubber. 
Although not novel, it has never been described fully in a publication. It is based 
on a survival analysis, using a Weibull distribution, of lap-shear samples aged at 
an increased temperature to accelerate the failure rate. We also discuss, for the 
first time, how to interpret the results in a general context, and offer an illustration 
with materials specifically selected for our application. Two adhesive silicone 
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rubbers are tested in vitro on typical implant substrates at worst-case stomach pH. 
The best one is proposed for a gastric implant and compared with historical 
standards.  
Methods 
This section describes the material selection, sample preparation, accelerated 
aging, event recording and standardized lap-shear method, statistical analysis and 
interpretation.  
Material selection 
The selected silicone rubbers are Dow Corning DC3140 and Nusil MED4-4220 
(see Table 1 for major properties). The selected substrates are glass, alumina and 
glass-reinforced epoxy (FR4).  
DC3140 was chosen because of its good adhesion to alumina [9, 10] and its wide 
use in the literature. It has long been considered the most suitable of 1-part 
silicone rubbers, amongst other because its cure evolves an alcohol, while most 1-
part silicone rubbers evolve acetic acid that may contribute to the corrosion of 
underlying metal surfaces. It is, however, not indicated for medical use and its 
cure requires atmospheric moisture, making it unsuitable for moulding [6]. 
Biocompatible MED4-4220 was developed by Nusil for encapsulating and was 
chosen as a newer silicone rubber presenting interesting properties such as a high 
tensile modulus and a wide range of cure temperatures and times (see Table 1). 
While 2-part silicone rubbers are suitable for moulding, they are unfortunately 
more sensitive to contamination than 1-part rubbers. Indeed, the platinum catalyst 
used for 2-part adhesives is very sensitive to contamination [27]. This can impede 
the chemical reactions between the two parts of the silicone rubber and prevent a 
complete cure, the resulting product remaining tacky at best. The catalysts used in 
1-part rubbers are less sensitive to poisoning. 
The adherent materials FR4 and alumina were chosen because they are typically 
used as electronic circuit substrates. Glass was also considered because its 
performance, with DC3140 as an adherent, in previous experiments at pH 4 was 
remarkable, and because the bonds of various silicone rubbers, including DC3140, 
to both glass and alumina have already been showed to be satisfactory [9, 10].  
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Sample assembly and cleaning 
All substrates measure 25.4 mm by 25.4 mm. Those dimensions were chosen to 
allow easy comparison with previous studies. The thickness was 1 mm for glass, 
0.7 mm for alumina and 1.6 mm for FR4. The impact of the substrate thickness on 
the long-term stability of the adhesive bond is unlikely to be significant. The 
water vapour will permeate through the silicone rubber in a matter of minutes to 
hour [33] while the water vapour permeability of the three substrate materials 
tested is comparatively much higher.  
The FR4 pieces were immersed in overactivated ferric chloride solution to remove 
the copper layer. This method is commonly used to remove copper from FR4 
when etching printed circuit boards.  
The substrates were cleaned with an alkaline cleaning solution containing 10 ml 
of Teepol and 250 g of Na3PO4 diluted in deionized water to 2 l. All parts were 
then rinsed in flowing deionized water until the conductivity of the rinse water, 
120 nS/cm at the output of the deionizer, was lower than 300 nS/cm when 
measured at the output of the rinsing bath.  
Each sample was built with two adherent pieces, bonded with silicone rubber. The 
adhesive layer had a 500 µm thickness and a 25.4 by 3 mm area (Fig. 2). Three 
different joining jigs were built, to accommodate for the different substrate 
thicknesses while keeping the adhesive layer thickness constant at 500 µm (Fig. 
3). The adhesive layer was first applied with a gun on the lower substrate (on the 
right side of the Fig. 2), before carefully laying the second substrate above. The 
bonded samples were then cured at 60° C overnight. 
Accelerated aging 
All samples were immersed in a simulated gastric fluid (DMC030-06 Simulated 
Gastric Fluid from ProSense B.V., Netherlands) at 100° C. It is the first time that 
such tests were performed in a simulated physiological fluid instead of distilled 
water.  
Working at this elevated temperature, much higher than that of the body, 
accelerates the failure rate. It does not however, to the best of our knowledge, 
introduce new failure modes not present at the operating temperature. We are 
therefore only studying the adhesive failures that would occur in use. 
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PEK Donaldson studied the underwater stability of the adhesive joints between 1 
and 2-part silicone rubbers and several adherents. He showed that the failure rate 
follows an Arrhenius relationship with temperature [12]. An acceleration factor, 
A, comparing the failure rates at two temperatures T and T+ΔT, can then be 
calculated using the following equation:  
    
  
 
  
 
 
 
 
    
          (1) 
where k is the Boltzmann constant and Ea the activation energy of the joint failure.  
The activation energy depends on the adhesive/substrate couple tested, as well as, 
to a lesser extend, the relative humidity and temperature [36]. Based on PEK 
Donaldson’s results for DC3140 on alumina at pH 7 between 70 and 100°C, an 
activation energy of 0.7 eV was used when calculating the acceleration factor (see 
section “Results”). 
Timing of lap-shear tests and recording of failures 
Lap-shear tests, pulling with a 5 kg force, were performed periodically. The 
intervals between the tests were defined as one tenth of the time from the 
beginning of the experiment or daily, whichever was the longer, meaning for 
example that until the 20th day, the samples were tested daily. It is worth noting 
that to keep a manageable number of samples, they were not removed after each 
“pull” but re-immersed in the gastric liquid, potentially accelerating further their 
failure rate. Consequently, the calculated survival rate is underestimated compared 
to an ideal case with removal of every sample tested.  
A test can have either of the three outcomes listed below. 
(a) The sample is intact, it is then returned to the boiler.  
(b) The adhesion between the silicone rubber and the substrate fails, an adhesive 
failure is recorded.  
(c) The sample fails in any other way (broken substrate, cohesive failure within 
the silicone rubber,...). The sample is excluded from further testing. This is 
recorded as a right-censored event. As the sample failed in a way that is not 
relevant to the study, it should not be excluded from the population. Right-
censorship allows us to consider the period it did survive, until it could no longer 
be tested, when computing the survival probability. The term right-censorship is 
best understood when imagining an axis of time, with the past to the left and the 
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future to the right. If a sample is excluded before the failure mode under study is 
observed, only an aborted survival time (left of the exclusion day) is known. The 
actual failure day would have occurred to the right of the exclusion day, hence the 
event is right-censored. 
Statistical analysis and interpretation 
We use a two-parameter Weibull distribution to represent the sample population 
[30]. This distribution is common in reliability analysis and its merits have been 
discussed elsewhere [26]. 
The probability density function (pdf), Eq. (2), gives the probability of a sample 
failing on a given day d (d>0). The cumulative density function (cdf), F(T), gives 
the probability of a sample having failed by time T (T>0). It can be used to 
calculate the probability of a sample surviving past T days. This last function is 
known as the reliability or survival function, commonly denoted by the letter R or 
S as in Eq. (3). 
     (
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β is the shape parameter or Weibull modulus, and η is the scale parameter and 
both are positive. The mean and standard deviation of the distribution, Eq. (4) and 
(5) respectively, are related to the gamma function. 
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Figure 4 depicts the gamma function Γ(x) and the Weibull distribution pdf. Γ(x) is 
1 for x=1 and x=2, has a minimum at xmin = 1.4616 where Γ(xmin) = 0.8856 and 
is > 1 for 0 < x < 1 and x > 2, as seen in Fig. 4a. Therefore, for β > 1, the Gamma 
function is between its minimum (0.89) and 1, and the mean of the distribution 
E(T) is such that 0.89 ∗ η ≤ E(T) ≤ η. The scale parameter (η) gives an 
approximation of the mean time to failure (MTF), hence η is sometimes called the 
characteristic life. The significance of the shape parameter (β) is illustrated in Fig. 
4b, showing Weibull pdfs, with the same scale parameter but different shape 
Encapsulation for gastrostimulator  Page nr. 10 of 22 
10 
parameters, all > 1. The higher the shape parameter, the higher the probability that 
the samples will fail at a time η and the narrower the standard deviation for a 
given η. Practically, β > 1 indicates wear out failures, for β = 1 the failure rate is 
independent of the time and for β < 1 it decreases with time.  
The data were analyzed using Matlab R2010. Maximum likelihood estimates 
(MLE) of the two parameters were calculated using the function wblfit, taking the 
right-censored data into account. The function also returns upper and lower 
bounds for the parameters, with a confidence index α which, unless otherwise 
stated, was 95 % for all data presented in this paper. The mean time to failure and 
standard deviation (std) for the population were then estimated (function wblstat 
or Eq. (4) and (5)), as well as the time by which there is an n % chance that a joint 
would have failed (and corresponding confidence interval CI). This last value is 
known as the nth percentile and denoted yn. 
The cdf of the distribution with the estimated parameters was then used to 
estimate the cumulative failure probabilities corresponding to the days at which 
failures were recorded. These probabilities and times to failure were plotted on 
probability axes, and the correlation coefficient and p-value calculated. Several 
data sets were plotted on the same graph for comparison (Fig. 5). The probability 
plots allow a visual inspection of the data sets to check if the assumption of a 
single failure mode is met. The data points should appear to be on a single line, 
without noticeable inflection (possibly indicative of a lognormal distribution) or 
corners, indicating a mixed failure modes situation.  
The MTF and std of the distribution, plus scale parameter (η) and shape parameter 
(β), and the R and p-value for all the sets tested are presented in Table 2. 
Results 
Figure 5 depicts the samples failure probability versus time for each 
adhesive/substrate couple at pH 1.  
The results are summarized in Table 2. The MTF ranges from 3.8 days (CI = 3.2 
days – 4.4 days) to 30.1 days (CI = 24.8 days – 36.5 days) depending on the 
adhesive/substrate couple. The MED4-4220/alumina couple offers the best 
adhesion with an MTF of 30.1 days. The MED4-4220/FR4 couple also has a high 
MTF (25.1 days with CI = 20.4 days – 30.9 days) but the Weibull shape parameter 
(β) is higher for MED4-4220/alumina (3.2) than for MED4-4220/FR4 (2.9). The 
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predicted MTF of the adhesive bonds at working temperature was estimated using 
an acceleration factor of 84 (Eq. (1)). The expected MTF at 37°C ranges from 
10.6 months (CI = 9 months – 12.3 months) to 7 years (5.8 years – 8.5 years) 
depending on the adhesive/substrate couple (see Table 3 for values extrapolated at 
37°C).  
Figure 6 compares the samples failure probability versus time for the MED4-
4220/alumina couple at pH 1 and pH 7, showing the impact of the acidity. The 
MTF value is 13.7 times lower at pH 1 (30.1 days) than at pH 7 (412.9 days).  
The standard 5 kg lap-shear test method was used to allow comparison with 
results from other studies. PEK Donaldson assessed the adhesive bond between 1-
part DC3140 and alumina at pH 4 and pH 7 [9]. We have calculated the MTFs 
and Weibull shape parameters from these published data and compared them to 
our results at pH 1. Figure 6 shows the influence of the acidic environment. The 
MTF values are respectively 94.1 at pH 7, 30.5 at pH 4 and 3.8 at pH 1 while the 
shape parameters are 5.5, 7.2 and 4.2, respectively. The MTF is thus 24.8 times 
lower at pH 1 than at pH 7 for the DC3140/alumina couple. This ratio is much 
higher than that of the MED4-4220/alumina couple (13.7 times lower at pH 1 than 
at pH 7; Fig. 6). Figure 6 also shows that the MTF is higher for the MED4-
4220/alumina couple than for the DC3140/alumina couple, both at pH 7 (4.4 times 
higher) and at pH 1 (7.9 times higher).  
Discussion 
Material selection for a gastric stimulator implant 
We have studied the long-term stability of the adhesive bond between several 
couples of substrate and adhesive in simulated gastric liquid. Two silicone rubbers 
were tested on typical implant substrates at worst-case stomach pH. The MED4-
4220/alumina couple offered the best adhesion with a MTF of 30 days at 100°C, 
resulting in a large predicted MTF at body temperature (7 years). The shape 
parameter was large and the cumulative failure probability for this couple reached 
10% at 17 days, meaning that there is only a 10 % chance that a sample will fail 
during the first 17 days. This corresponds to 3.9 years at 37°C, sufficient for a first 
implantable prototype (see Table 3 for values extrapolated at 37°C).  
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Comparison with gastric balloons 
Gastric balloons are interesting to compare to our gastric stimulators for at least 
two reasons: i) both devices aim to fight obesity (hence are competitors) and ii) 
both should resist the gastric environment (as discussed in the next section). 
Gastric balloons are typically used to fight obesity though with limited efficiency. 
Some of their major shortcomings include gastric ulceration, intolerance, 
difficulty in inflating or deflating the balloon, and spontaneous deflation of the 
balloon causing subsequent obstruction and complications during balloon 
withdrawal [4, 14, 32, 39]. Since some of these complications have been 
associated with prolonged gastric implantation times [4] [28], the manufacturers 
typically recommend removal of gastric balloons six months after implantation [4, 
14]. Therefore, the extrapolated MTF of 7 years and a 10th percentile at 3.9 years, 
reported in this paper, are sufficient to propose gastrostimulator implants as 
advantageous alternatives to gastric balloons.  
The role of lipids and compression forces in the degradation of 
silicone rubbers 
We used a commercial simulated gastric fluid in our tests. Its composition is 
proprietary but the manufacturer confirmed that it is a mix of hydrochloric acid 
and sodium chloride without lipids or enzymes. While this choice follows industry 
standards [24], the gastric implant will be in contact with various other substances 
present in the food ingested by the patient. Lipids, for instance, are known to alter 
the cohesive strength of silicone rubbers [34, 37]. Gastric balloons are typically 
made of silicone elastomer [13, 31]. One of their modes of failure is related to the 
gastric environment weakening the material [4, 16], which can lead to 
spontaneous deflation and resultant bowel obstruction [14]. This type of failure is 
related to the cohesive deterioration of the silicone elastomer while our study 
focuses on the adhesion between the silicone rubber and the substrate. The 
presence of lipids in the simulated gastric fluid would most certainly affect the 
bulk of the adhesive, resulting in cohesive failures, or right-censored events. 
However, cohesive strength is not a predictor of adhesive quality [7–9, 11]. 
Hence, while we cannot exclude that the lipids may also have an impact on the 
adhesive strength, we believe that the material selection method, and the results, 
presented here remain valid.  
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Furthermore, gastric balloons are also subject to compression forces (natural 
peristalsis) when the stomach attempts to move them downstream. These 
compression forces combined with the presence of lipids could lead to a 
premature failure of the silicone rubber. In the case of our device, because of its 
smaller size and way of anchoring to the stomach wall (see following section), 
such compressions are not applied to it. This also argues in favour of our device.  
Considerations for the manufacture of a gastric stimulator implant 
Our group is currently developing a gastric stimulator prototype (Fig. 7). Based on 
the results of this study, alumina was chosen for the substrate and MED4-4220 for 
the adhesive. The device’s physical design was conceived to permit anchoring by 
endoscopy. It is patented (Priority Date: 2009/05/08; Application number: 
PCT/EP2010/056378) and has been described elsewhere [25]. The electronic 
design and stimulation protocol are also described in [25].  
For our prototype, as for any implant using silicone rubber encapsulation, the 
adhesive bond degradation could be quicker than predicted for various reasons. 
When encapsulating in silicone rubber an implant that includes soldered 
components, the solder should also be considered. The adhesive bond to solder is 
generally weaker than to the substrates tested [12] and the presence of flux can 
drive corrosion. 
Cleanliness before encapsulation will also strongly influence the implant's lifetime 
[36]. Briefly, the cleaner the whole circuit and the substrate, the higher the 
osmotic gradient, should water vapour, which will rapidly permeate the 
encapsulation layer, find a condensation site. Liquid water formation would 
therefore be limited, and what would form would be highly resistive, hence 
limiting further loss of adhesion, and corrosion. 
On our prototypes, we used a water soluble flux and the devices, after population, 
were thoroughly cleaned. After a rapid rinse in deionized water to flush the water 
soluble flux, they were immersed for several minutes in chloroform while a visual 
inspection, under a microscope, was conducted to identify any residual flux. After 
drying in air, the samples were cleaned in iso-propanol, and finally in the alkaline 
solution described before. None of the cleaning stages were precisely timed as we 
relied on visual inspection of critical points to assess the efficacy of the procedure. 
Eventually, the samples were rinsed three times in deionized water before a final 
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rinse in flowing deionized water until the conductivity of the water flowing from 
the rinsing chamber reached an average value of 300 nS/cm. 
The presence of voids or air bubbles in the encapsulant may also negatively affect 
the implant's lifetime. Using the silicone rubber straight from the cartridge, 
without pre-processing, results in a surprisingly large number of small bubbles in 
the bulk of the silicone, as seen on the photograph of Fig. 8. Voids in the bulk of 
the silicone rubber, that are not in contact with the substrate or any part of the 
circuit, are not such a concern. If the substrate is thoroughly cleaned, the bubbles 
will become rapidly saturated with water vapour. Yet, as explained previously, 
even if some of it condenses, the osmotic gradient will drive it out of the bubble. 
Voids at the interface however are more troublesome as they decrease the overall 
surface area available for the silicone rubber to bond to the substrate. They also 
provide relatively large condensation sites for water vapour, where, if there is 
even minimal ionic contamination, the liquid water may support corrosion. 
In this respect, our tests samples were sub-optimal. This may have accelerated the 
failure rate, hence our results may underestimate the survival rate that could be 
achieved with bubble-free adhesive. We have adapted our method to prevent the 
formation of these voids and air bubbles in our prototypes. 
The MED4-4220 is degazed in a vacuum centrifuge for not more than 5 minutes 
at 25 mbar before being poured in the reservoir of the mould. After centrifugal 
casting during 2 to 5 minutes, the filled mould is cured in an oven during 2 hours 
minimum, sufficient to crosslink the silicone rubber. 
A final consideration when designing an implant is that the failure rate of 
electronic devices protected by silicone rubber encapsulation is proportional to the 
field-strength between exposed conductors. We have taken care, during the 
electronic design, to minimise these fields.  
Other applications in implanted devices 
Besides the direct benefit for gastric implants, our research also has implications 
for various other applications. Due to the current manufacturing bottleneck in 
implanted device protection (see introduction), silicone rubber encapsulation has 
recently received an increased interest [35, 36]. A manufacturing breakthrough is 
needed to enable technical applications requiring small dimensions and high 
reliability [18, 42]. Most of them fall into the area of electrical stimulation, one of 
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the fastest-growing areas of medicine, improving the lives of hundreds of 
thousands of patients with various disorders [23]. Visual prostheses are perhaps 
the most striking example with clear space constraints for which the current 
protection methods are not suitable [29]. 
Silicone rubber encapsulation offers a simple yet reliable way to protect implants. 
Using this method, prototypes using discrete components may be designed and 
developed rapidly. Besides prototypes, implants encapsulated with silicone rubber 
have been in use, in patients, for decades, demonstrating the suitability of the 
method for commercial production [2]. 
Conclusion 
We have presented a method to select a silicone rubber for the encapsulation of an 
electronics circuit to provide long-term protection for implantation. We have 
presented the event recording and failure analysis in depth. In this paper we have 
used the method to identify a suitable silicone rubber/substrate couple for the 
production of an implantable gastrostimulator.  
Compared to previous publications, this study is of major importance for two 
reasons. First, the samples were immersed in a pH equivalent to the stomach 
environment, which is lower than the acidity levels previously tested. Second, a 
new rubber was introduced and tested.  
This study shows that this promising technique is also suitable for devices 
operating in highly acidic environments. In particular, the combination of alumina 
with MED4-4220 may provide up to 3.9 years at body temperature with less than 
10% failed devices, hence is suitable for most gastrostimulator applications. This 
is of major importance in the fight against obesity as these implants could 
improve the well-being of obese patients during and after their medical 
intervention. Further work will include implanting stimulators in animal models to 
improve the endoscopic attachment method and assess the weight loss during 
stimulation at the pylorus. It will also include an analysis of the impact of various 
substances present in the food to complement the results presented here. 
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Figure captions 
Fig. 1 Sketches comparing examples of the encapsulation (a) and hermetic packaging (b) as 
methods of protecting an IC for human implantation  
Fig. 2 Two adherent pieces bonded with an adhesive layer of silicone rubber. The thickness is 500 
µm thickness and the area is 25.4 mm per 3 mm  
Fig. 3 Joining jig and its dimensions allowing the correct thickness of the adhesive layer 
Fig. 4 (a) Gamma function (b) Weibull distribution pdf with the same scale parameter and 
different shape parameters : squares are for beta = 10, mean = 9.5135, std = 1.1446, crosses are for 
beta = 4, mean = 9.064, std = 2.5429, triangles are for beta = 2, mean = 8.8623, std = 4.6325, 
circles are for beta = 1.1, mean = 9.6491, std = 8.7828 
Fig. 5 Weibull plots for the different couples tested at pH 1: asterisks are for DC3140/alumina, 
open circles are for DC3140/FR4, crosses are for MED4-4220/glass, squares are for 
DC3140/glass, triangles are for MED4-4220/FR4, closed circles are for MED4-4220/alumina  
Fig. 6 Influence of the acidic environment: asterisks are for DC3140/alumina at pH 1, closed 
circles are for MED4-4220/alumina at pH 1, triangles are for DC3140/alumina at pH 4, crosses are 
for DC3140/alumina at pH 7, squares are for MED4-4220/alumina at pH 7 
Fig. 7 Illustration of our first prototype of an encapsulated gastrostimulator 
Fig. 8 Illustration (optical photograph) of water bubbles between the substrate and the silicone 
after an adhesive failure (top view) 
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Tables 
Table 1. Main properties of DC3140 and MED4-4220 
 DC3140 MED4-4220 
Manufacturer Dow Corning Nusil 
Cure system Alkoxy Platinum 
Work time 25 min 25 min 
Mix ratio 1-part 2-part 1:1 
Cure time 72 h @ RT 15 min @ 150°C 
24 h @ RT 
Durometer Hardness Shore A 32 17 
Tensile modulus (MPa) 0.7  
Tensile strength (Mpa) 3.1 4.5 
Tear strength (kN/m) 3.6 5.3 
Uncured viscosity (mPa.s) 35950 20500 
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Table 2. Results (samples bathed at 100°C) 
 Scale 
parameter 
(η) [days] 
Shape 
parameter 
(β) [ ] 
MTF 
[days] 
Std of 
cdf 
[days] 
Pr<0.1 
[days] 
R 
[ ] 
P value 
[ ] 
DC3140/Al2O3  
(pH 1) 
4.1 4.2 3.8 1 2.4 0.83 48.44 
e-05 
DC3140/FR4  
(pH 1) 
9.7 3.2 8.7 2.9 4.8 0.86 7.09 
e-05 
DC3140/Glass  
(pH 1) 
16 2.6 14.2 5.9 6.7 0.97 3.53 
e-07 
MED4-4220/Al2O3  
(pH 1) 
33.6 3.2 30.1 10.3 16.6 0.93 5.44 
e-06 
MED4-4220/FR4  
(pH 1) 
28.1 2.9 25.1 9.3 13 0.98 2.31 
e-09 
MED4-4220/Glass  
(pH 1) 
9.4 10.4 9 1 7.6 0.94 4.37 
e-07 
DC3140/Al2O3 
(pH 4) 
32.5 7.2 30.5 5 23.8 0.91 57.21 
e-05 
DC3140/Al2O3 
(pH 7) 
101.9 5.5 94.1 19.8 67.6 0.94 20.05 
e-05 
MED4-4220/Al2O3 
(pH 7) 
451.4 1.4 412.9 305.3 87.1 0.95 4.57 
e-07 
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Table 3. Results at 100°C and extrapolated values at 37°C 
 Results at 100°C Extrapolated values at 37°C 
 MTF  
[days] 
Pr<0.1 
[days] 
MTF 
[years] 
Pr<0.1 
[years] 
DC3140/Al2O3  
(pH 1) 
3.8  2.4  0.9 0.6 
DC3140/Glass  
(pH 1) 
14.2  6.7  3.3  1.6  
DC3140/FR4  
(pH 1) 
8.7  4.8  2  1.1  
MED4-4220/Al2O3  
(pH 1) 
30.1  16.6  7  3.9  
MED4-4220/Glass  
(pH 1) 
9  7.6  2.1  1.8  
MED4-4220/FR4  
(pH 1) 
25.1  13  5.9  3  
DC3140/Al2O3 
(pH 4) 
30.5  23.8  7.1  5.6  
DC3140/Al2O3 
(pH 7) 
94.1  67.6  22  15.8  
MED4-4220/Al2O3 
(pH 7) 
412.9  87.1  96.3  20.3  
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